Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.89 EUR | +0.10% | -0.10% | -28.85% |
05-22 | VIB Vermögen Plans Squeeze-out of BBI Minority Shareholders | MT |
04-30 | VIB Vermögen AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 128M 137M 188M | Sales 2023 | 103M 110M 150M | Capitalization | 459M 492M 673M |
---|---|---|---|---|---|
Net income 2022 | 53M 56.74M 77.62M | Net income 2023 | 130M 139M 190M | EV / Sales 2022 | 9.61 x |
Net Debt 2022 | 671M 718M 982M | Net Debt 2023 | 693M 741M 1.01B | EV / Sales 2023 | 11.2 x |
P/E ratio 2022 |
10.7
x | P/E ratio 2023 |
3.55
x | Employees | 41 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.86% |
1 day | +0.05% | ||
1 week | -0.10% | ||
Current month | -3.98% | ||
1 month | -9.76% | ||
3 months | +4.99% | ||
6 months | -29.96% | ||
Current year | -28.85% |
Managers | Title | Age | Since |
---|---|---|---|
Dirk Oehme
CEO | Chief Executive Officer | 49 | 22-03-21 |
Peter Njuguna
CTO | Chief Tech/Sci/R&D Officer | 51 | 13-12-31 |
Henry Karanja
CMP | Compliance Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 23-02-05 | |
Gerhard Schmidt
CHM | Chairman | 67 | 22-04-12 |
Sonja Wärntges
BRD | Director/Board Member | 57 | 22-04-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 17 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-20 | 9.89 | +0.10% | 2 310 |
24-06-19 | 9.88 | -2.37% | 242 |
24-06-18 | 10.12 | +2.12% | 5,547 |
24-06-17 | 9.91 | 0.00% | 2,866 |
24-06-14 | 9.91 | +0.10% | 6,213 |
Delayed Quote Xetra, June 20, 2024 at 11:36 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.85% | 351M | |
+23.63% | 25.65B | |
+20.39% | 25.52B | |
-2.68% | 25.21B | |
-15.87% | 25.11B | |
+2.62% | 20.19B | |
+25.09% | 19.79B | |
-1.14% | 18.79B | |
+54.74% | 18.43B | |
-5.15% | 15.76B |
- Stock Market
- Equities
- VIH1 Stock